Sleep Cycle AB (SLEEP)
Stockholm Exchange · Sweden · prices in SEK · close of 19 Oct 2026
Key indicators
| Last close | SEK 24.05 |
|---|---|
| 52-week range | 14.65 – 27.12 |
| Return, 1 month / 3 months | +4.6% / −1.8% |
| Return, 1 year / 3 years | −5.8% / +26.2% |
| Trend | Uptrend |
| RSI (14) | 62 |
| Volatility (1 year) | 64.4% |
| Worst drawdown (1 year) | -44.6% |
| Average daily value traded | 0.19M SEK |
| Dividend yield | 2.2% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Sleep Cycle AB makes a mobile application that tracks and analyses sleep. The app uses the microphone and motion sensors of a smartphone to detect movement and breathing patterns during the night, then presents the results as charts and statistics. It also offers a smart alarm that wakes the user gently during lighter sleep within a chosen time window. The company is based in Gothenburg, Sweden, and its customers are individual users of the app around the world.
The shares are listed on the Stockholm Exchange in Sweden under the code SLEEP, and the price on this page is in Swedish kronor (SEK). Our dividend records, which start in 2019, show payments in 4 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Sleep Cycle AB (SLEEP) trades on the Stockholm Exchange in Sweden. It last closed at SEK 24.05 on 19 October 2026.
Its price-based Market X-Ray is 55 out of 100 (a fair price profile), ranking 407 of 911 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 5.8% and over the last three months it fell 1.8%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Stockholm Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 80 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 12.2% | ||
| From 52-week high | -9.7% | ||
| Momentum | 65 · Fair | Typical recent returns for this exchange. | |
| 3-month return | -1.8% | ||
| 6-month return | 34.1% | ||
| 12-month return, skipping the last month | -9.9% | ||
| Stability (higher is calmer) | 39 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 64.4% | ||
| Worst drawdown, 1 year (smaller is calmer) | -44.6% | ||
| Liquidity | 38 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.19M SEK | ||
| Zero-volume days | 0.0% | ||
| Income | 32 · Weak | Dividend is small or irregular. | |
| Dividend yield | 2.2% | ||
| Years with dividends | 4 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
Weak spots
- Stability (higher is calmer): Volatile, with deep drawdowns.
- Liquidity: Thinly traded: prices can jump and exits can be hard.
- Income: Dividend is small or irregular.
Returns
| 1 week | +0.2% |
|---|---|
| 1 month | +4.6% |
| 3 months | −1.8% |
| 6 months | +34.1% |
| 1 year | −5.8% |
| 3 years | +26.2% |
| 5 years | – |
Signals
| 50-day / 200-day average | 22.77 / 21.44 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.95 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 14 Apr 2026 | SEK 0.5300 |
| 9 Apr 2025 | SEK 1.8500 |
| 12 Apr 2024 | SEK 1.3000 |
| 9 May 2023 | SEK 1.0000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Stockholm Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.